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Abstract 
PROTEOGENOMIC ANALYSES OF LINGO-1 AND THE NOGO RECEPTOR IN 
SCHIZOPHRENIA 
Andrews, J., Newell, K., Fernandez, F. 
1. Centre for Translational Neuroscience, School of Health Sciences, University of Wollongong, Australia  
2. Schizophrenia Research Institute, Sydney, Australia 
 
Purpose: Schizophrenia is a severe neuropsychiatric disorder with an elusive aetiology, thought to 
result from abnormal brain development.  Nogo, an oligodendrocyte bound molecule responsible for 
CNS myelin regulation, neurite outgrowth and plasticity during neurodevelopment, binds to its 
receptor NgR, located on axonal membranes and interacts with its co-receptor Lingo-1.  This study 
investigated polymorphisms within the Lingo-1 and NgR genes in schizophrenia; and examined the 
Lingo-1 and NgR protein levels within the human dorsolateral prefrontal cortex (DLPFC) in 
schizophrenia.   
Methods: Human matched case control DNA samples (n=268/group) from the Australian 
Schizophrenia Research Bank were purified and then genotyped to assess polymorphisms within the 
Lingo-1 and NgR genes using restriction fragment length polymorphism, and Multiplex MassARRAY 
genotyping assays.  Human DLPFC matched case control samples (n=37/group) from the NSW 
Tissue Resource Centre were used to assess Lingo-1 and NgR protein levels by immunoblotting.  
Results: One genetic marker, NgR rs701427, had a significant association with schizophrenia (p = 
0.02).  NgR protein expression was significantly decreased by 16% (p < 0.001) and Lingo-1 protein 
expression was significantly increased by 12% (p = 0.006) in the DLPFC of schizophrenia subjects. 
There was a significant correlation between NgR and Lingo-1 protein levels (p = 0.017). 
Conclusion: This study shows strong evidence for NgR/Lingo-1 involvement in schizophrenia in both 
genetics and protein.  The NgR and Lingo-1 gene mutations found to be associated with schizophrenia 
in this study may result in the dysregulated NgR and Lingo-1 protein expression.  Further studies are 
required in order to investigate the implications of these genetic and proteomic alterations to the 
aetiology of schizophrenia. 
